My brother has Multiple System Atrophy, a “cousin” to Parkison’s disease and also a synucleinopathic disease. I am interested in Lundbeck Pharmaceutical’s clinical trial for LuAF82422, a monoclonal antibody. In February of 2025 the 3rd clinical trial will be finished. / also anti inflammation drugs interest me.
Report
There was a problem reporting this post.
Block Member?
Please confirm you want to block this member.
You will no longer be able to:
See blocked member's posts
Mention this member in posts
Invite this member to groups
Message this member
Add this member as a connection
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.